Wellgistics Selects Five Blockchain Platforms for PharmacyChain™ Rollout to 6,500+ Pharmacies by Q2 2026
Wellgistics Health selected Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu and Corda for its PharmacyChain™ smart-contract drug-tracking system, aiming for HIPAA-compliant rollout by end of Q2 2026. It will roll out to 6,500+ pharmacies later this year to tap a US prescription market set to expand from $634B to $883B by 2030.
1. Blockchain Platforms Selected
Wellgistics Health conducted an evaluation and selected Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu and Corda (R3) as the foundation for PharmacyChain™, its patented smart-contract platform designed to track pharmaceutical products and ensure compliance with serialization mandates.
2. Network Rollout Plans
Development work will focus on establishing closed-loop, HIPAA-compliant data transfers within Wellgistics’ pharmacy, with completion targeted by end of Q2 2026, followed by rollout to its 6,500+ pharmacy network later this year to streamline drug tracing and serialization.
3. Market Opportunity and IP Advantage
The initiative leverages Wellgistics’ exclusive intellectual property license from Datavault AI and addresses a US prescription market projected to grow from $634B to $883B by 2030, while positioning the company in a blockchain healthcare sector expanding from $11B to $214B by 2030.